I.31, a new combination of probiotics, improves irritable bowel syndrome-related quality of life

Figure 3 Irritable bowel syndrome-related quality of life score response to probiotic and placebo therapy. Good response was defined as score improvement ≥ 15 points; poor response as score improvement 10-15 points; and non-response as score improvement < 10 points. The number of responders (score increment > 10) was significantly larger in both groups of patients treated with probiotics than in those treated with placebo (χ² test). IBSQoL: Irritable bowel syndrome-related quality of life.